NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases (Q33930920)

30 July 2017

1 reference

title

NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases (English)

1 reference

30 July 2017

0 references

Schmid RM

1

1 reference

PubMed ID

10833496

30 July 2017

Adler G

series ordinal

2

1 reference

PubMed ID

10833496

30 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

30 July 2017

1 reference

30 July 2017

118

1 reference

30 July 2017

6

1 reference

30 July 2017

1208-1228

1 reference

Multiple nuclear factors interact with the immunoglobulin enhancer sequences

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Proposed NF- B/I B family nomenclature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Structure, regulation and function of NF-kappa B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Generation of p50 subunit of NF-kappa B by processing of p105 through an ATP-dependent pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Ubiquitin-mediated processing of NF-kappa B transcriptional activator precursor p105. Reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2, and a novel ubiquitin-protein ligase, E3, involved in conjugation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

The precursor of NF-kappa B p50 has I kappa B-like functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Transcriptional induction of the alpha-1 acid glycoprotein (AGP) gene by synergistic interaction of two alternative activator forms of AGP/enhancer-binding protein (C/EBP beta) and NF-kappaB or Nopp140.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Autoregulation of I kappa B alpha activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Chemokine gene expression in rat pancreatic acinar cells is an early event associated with acute pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Regulation of the human P-selectin promoter by Bcl-3 and specific homodimeric members of the NF-kappa B/Rel family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

NF-kappa B binds within a region required for B-cell-specific expression of major histocompatibility complex class II gene E alpha d

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Identification of a functional NF-kappa B binding site in the murine T cell receptor beta 2 locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Tumor necrosis factor alpha and interleukin-1beta regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-beta and NF-kappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Role of a distal enhancer containing a functional NF-kappa B-binding site in lipopolysaccharide-induced expression of a novel alpha 1-antitrypsin gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Structure of the promoter for the rat Fas antigen gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

A critical role for the RelA subunit of nuclear factor kappaB in regulation of multiple immune-response genes and in Fas-induced cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Interleukin 1beta induces type II-secreted phospholipase A(2) gene in vascular smooth muscle cells by a nuclear factor kappaB and peroxisome proliferator-activated receptor-mediated process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Regulation of Fas-dependent activation-induced T cell apoptosis by cAMP signaling: a potential role for transcription factor NF-kappa B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Characterization of the promoter for the human long pentraxin PTX3. Role of NF-kappaB in tumor necrosis factor-alpha and interleukin-1beta regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Pyrrolidine dithiocarbamate differentially affects cytokine- and cAMP-induced expression of group II phospholipase A2 in rat renal mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

5'-flanking region surrounding a human cytosolic phospholipase A2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Interaction of NF-kappaB and NFAT with the interferon-gamma promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Induction of the gene encoding mucosal vascular addressin cell adhesion molecule 1 by tumor necrosis factor alpha is mediated by NF-kappa B proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Transcriptional regulation of NF-kappa B2: evidence for kappa B-mediated positive and negative autoregulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

NF-kappa B-dependent Fas ligand expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Insulin antiapoptotic signaling involves insulin activation of the nuclear factor kappaB-dependent survival genes encoding tumor necrosis factor receptor-associated factor 2 and manganese-superoxide dismutase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

The Toll-receptor family and control of innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Proteolytic degradation of MAD3 (I kappa B alpha) and enhanced processing of the NF-kappa B precursor p105 are obligatory steps in the activation of NF-kappa B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

In vivo control of NF-kappa B activation by I kappa B alpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha is a signal for its degradation but not dissociation from NF-kappa B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Critical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of I kappa B-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Phosphorylation of p105 PEST sequence via a redox-insensitive pathway up-regulates processing of p50 NF-kappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

A sustained reduction in IkappaB-beta may contribute to persistent NF-kappaB activation in human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Regulation of NF-kappa B activity by I kappa B alpha and I kappa B beta stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Rapid Up-regulation of IκBβ and Abrogation of NF-κB Activity in Peritoneal Macrophages Stimulated with Lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Role of unphosphorylated, newly synthesized I kappa B beta in persistent activation of NF-kappa B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Cloning and functional characterization of mouse IkappaBepsilon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

IkappaB kinase-alpha and -beta genes are coexpressed in adult and embryonic tissues but localized to different human chromosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T-cell lymphomas and in T-cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Induction of NF-kappaB by the Akt/PKB kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Activation of transcription factor NF-kappaB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

A growing coactivator network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Versatile molecular glue. Transcriptional control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

CREB-binding protein/p300 are transcriptional coactivators of p65

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

IL-6 and NF-IL6 in acute-phase response and viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Mechanism for biphasic rel A. NF-kappaB1 nuclear translocation in tumor necrosis factor alpha-stimulated hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Two adjacent C/EBP-binding sequences that participate in the cell-specific expression of the mouse serum amyloid A3 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

A 58-base-pair region of the human C3 gene confers synergistic inducibility by interleukin-1 and interleukin-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

The cytokine response element of the rat alpha 1-acid glycoprotein gene is a complex of several interacting regulatory sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

A multiple cytokine- and second messenger-responsive element in the enhancer of the human interleukin-6 gene: similarities with c-fos gene regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Activation of interleukin-6 gene expression through the NF-kappa B transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Hepatic lipocytes: the principal collagen-producing cells of normal rat liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Identification, culture, and characterization of pancreatic stellate cells in rats and humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

NF-kappaB/Rel activation in cerulein pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

NF-kappaB activation in acute pancreatitis: protective, detrimental, or inconsequential?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Inhibition of nuclear factor-kappaB activation improves the survival of rats with taurocholate pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Cytokines in acute pancreatitis--new pathophysiological concepts evolve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

A role for transcription factor NF-kappa B in intestinal inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Effects of steroid treatment on activation of nuclear factor kappaB in patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Activation of nuclear factor kappa B inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Regulation of gene expression with double-stranded phosphorothioate oligonucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Inhibition of phorbol ester-induced cellular adhesion by competitive binding of NF-kappa B in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Mediation by NF-kappa B of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Inhibition of NF-kappa B by sodium salicylate and aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Inhibition of interleukin-1-stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Anti-inflammatory actions of steroids: molecular mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Transcriptional cross-talk, the second mode of steroid hormone receptor action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1beta-induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-kappa B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Site-specific tyrosine phosphorylation of IkappaBalpha negatively regulates its inducible phosphorylation and degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Role of reactive oxygen intermediates in interleukin 10 release after cold liver ischemia and reperfusion in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Infection of human intestinal epithelial cells with invasive bacteria upregulates apical intercellular adhesion molecule-1 (ICAM)-1) expression and neutrophil adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Activation of NF-kappaB in intestinal epithelial cells by enteropathogenic Escherichia coli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Yersinia enterocolitica impairs activation of transcription factor NF-kappaB: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor alpha production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Epithelial cell-initiated inflammation plays a crucial role in early tissue damage in amebic infection of human intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Role of the proteasome in rat indomethacin-induced gastropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Less degradation, more shock, please

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Hepatitis B virus X protein transactivates the long terminal repeats of human immunodeficiency virus types 1 and 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

The hepatitis B virus large surface protein (LHBs) is a transcriptional activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Characterization of the hepatitis B virus preS/S region encoded transcriptional transactivator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Malignant transformation by mutant Rel proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Rel/NF-kappa B and I kappa B factors in oncogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Transcriptional cross talk between NF-kappaB and p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Association of Cdk2/cyclin E and NF-kappa B complexes at G1/S phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-kappaB2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Identification and characterization of a novel monocyte/macrophage differentiation-dependent gene that is responsive to lipopolysaccharide, ceramide, and lysophosphatidylcholine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFkappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Severe liver degeneration in mice lacking the IkappaB kinase 2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Limb and skin abnormalities in mice lacking IKKalpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

IKK1-deficient mice exhibit abnormal development of skin and skeleton

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Liver regeneration in health and disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

NFkappaB prevents apoptosis and liver dysfunction during liver regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of transcription factors NF-kappaB and AP-1 or with expression of tumor necrosis factor alpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Regulation of immune responses by NF-kappa B/Rel transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Requirement for NF-kappaB in osteoclast and B-cell development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Expression of relB is required for the development of thymic medulla and dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Differential nuclear localization of p50, p52, and RelB proteins in human accessory cells of the immune response in situ.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Functional redundancy of the nuclear factor kappa B inhibitors I kappa B alpha and I kappa B beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Immunological defects in mice with a targeted disruption in Bcl-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

Control of NF-kappa B activity by the I kappa B beta inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

7 January 2021

Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

7 January 2021

Transcriptional trans-activating function of hepatitis B virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

7 January 2021

Activation of class I major histocompatibility complex gene expression by hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

7 January 2021

Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

7 January 2021

Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970374-X

7 January 2021

10.1016/S0016-5085(00)70374-X

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10833496